Is Sun Pharma FDA approved?
(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate companies) today announced that it has received approval from the U.S. Food and Drug Administration (USFDA) for INFUGEM™ (gemcitabine in 0.9% sodium chloride injection) 10 mg/mL, for intravenous …
Is Sun Pharma reputable?
Sun Pharma is a good company, but the work culture at the Mohali plant is worse. Huge pressure is there due to the shortage of manpower. People are pressurized to stay on a routine basis. there is no work-life balance.
What is the problem with Sun Pharma?
That warning cited several problems at Sun’s Karkhadi, Gujarat facility including deficient cGMP manufacturing practices for both APIs and finished drug products sold in the US. “These violations and deviations cause your drug products and APIs to be adulterated,” said the FDA.
Is Sun Pharma listed in US?
In the United States, the company markets a large basket of generics, with a strong pipeline awaiting approval from the U.S. Food and Drug Administration (FDA). Sun Pharma was listed on the stock exchange in 1994 in an issue oversubscribed 55 times. The founding family continues to hold a majority stake in the company.
Is metformin by Sunpharma recalled?
Update [10/5/2020] FDA is alerting patients and health care professionals to two voluntary recalls of extended release (ER) metformin by Marksans Pharma and Sun Pharmaceutical Industries. The companies are recalling metformin because it may contain N-nitrosodimethylamine (NDMA) above the acceptable intake limit.
Why did Sun Pharma acquired Ranbaxy?
Key Impact and Rationale of the transaction: The transaction will combine Sun Pharma’s proven complex product capabilities with Ranbaxy’s strong global footprint, leading to significant value creation opportunities.
Why Sun Pharma is in loss?
Read more news on During the quarter, the company reported a one-time exceptional loss of Rs 631 crore in relation to payments made for settlement of antitrust litigations filed by the US Department of Justice against arm Taro Pharmaceutical Industries as well as impairment of certain assets.
What is the future of Sun Pharma?
Analyst Future Growth Forecasts Revenue vs Market: SUNPHARMA’s revenue (9.9% per year) is forecast to grow slower than the Indian market (12.7% per year). High Growth Revenue: SUNPHARMA’s revenue (9.9% per year) is forecast to grow slower than 20% per year.
Why are doctors no longer prescribing metformin?
In May 2020, the Food and Drug Administration (FDA) recommended that some makers of metformin extended release remove some of their tablets from the U.S. market. This is because an unacceptable level of a probable carcinogen (cancer-causing agent) was found in some extended-release metformin tablets.
Why is metformin bad for you?
This is because an unacceptable level of a probable carcinogen (cancer-causing agent) was found in some extended-release metformin tablets. If you currently take this drug, call your healthcare provider. They will advise whether you should continue to take your medication or if you need a new prescription.